ACE2 and COVID-19: Further research with real SARS-CoV-2 virus infection is required to evaluate the therapeutic effects of ACE2-MSCs on COVID-19 and to better understand the mechanism through which ACE2-MSCs modulate cellular and signaling networks in response to microenvironmental cues in COVID-19.